Jain PharmaBiotech

Blaesiring 7
Basel, CH-4057, Switzerland
Switzerland

Phone: +4161- 6924461
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Jain PharmaBiotech was formed to conduct research, provide consulting services, and publish strategic reports for the pharmaceutical and biotechnology industries. Consultations performed include a variety of assignments from various companies, which include technology assessment, competitive intelligence, market analysis, design of clinical trials and finding innovative solutions for problems.

Activities

O Research and documentation of various technologies: genomics, proteomics, molecular diagnostics, nanobiotechnology, RNA interference, and drug delivery.
O Integration of biotechnologies for development of personalized medicine
O Research in gene therapy of brain tumors:preclinical investigation of destruction of glioblastoma multiforme by genetically modified bacteria.
O Planning and protocols of clinical trials of drugs for neurological disorders.
O Publication of reports on biotechnology, which are constantly updated. Current topics include:

-Alzheimers disease: new Drugs, markets, and companies, 2020
-Animal Biotechnology: technologies, markets & companies, 2020

-Antiviral Therapeutics: technologies, markets & companies, 2020

-Biomarkers: technologies, markets and companies, 2020

-Cardiovascular Drug Delivery, 2020

-Cell therapy: technologies, markets and companies, 2020

-Cytogenetics: technologies, markets and companies, 2020

-DNA Sequencing, 2020

-Drug Delivery in Cancer:technologies,markets & companies, 2020

-Drug Delivery in Disorders of the Central Nervous System, 2020

-Gene therapy: technologies, markets & companies, 2020

-Molecular diagnostics: technologies, markets &companies, 2020

-Nanobiotechnology: applications, markets and companies, 2020

-Neuroprotection: drugs, markets & companies, 2020

-Nitric Oxide: therapeutics, markets & companies, 2020

-Pain Therapeutics: drugs, markets & companies, 2020

-Personalized Medicine: scientific basis, markets & companies, 2020

-Proteomics: technologies, markets & companies, 2020

-RNAi: technologies, markets & companies, 2020

-Transdermal Drug Delivery, markets & companies, 2020

-Therapeutic Drug Monitoring, markets & companies, 2020

O Authoring and editing of textbooks. Currents books are:

-Jain KK. Handbook of Nanomedicine, Humana/Springer, 3rd ed, 2017.

-Jain KK (ed). Drug Delivery Systems, Humana/Springer, 3rd ed, 2019.

-Jain KK. Textbook of Hyperbaric Medicine, Springer, 6th ed 2017.

-Jain KK. Textbook of Personalized Medicine, Springer, 3rd ed, 2020.

-Jain KK (ed). Drug Delivery in Central Nervous System, Springer, 2010.

-Jain KK. Handbook of Biomarkers, Springer, 2nd ed, 2017.

-Jain KK. Handbook of Neuroprotection, Springer, 2nd ed, 2019.

-Jain KK. Applications of Biotechnology in Cardiovascular Therapeutics. Springer, 2011.

-Jain KK. Drug-induced Neurological Disorders, 4th ed. Springer, 2020.

-Jain KK (ed) Nanooncology. Clinics Lab Med, Elsevier, 2012.

-Jain KK. Handbook of Nanomedicine, 3nd ed, Humana/Springer, 2017.

-Jain KK. Applications of Biotechnology in Neurology, Springer 2013.

-Jain KK. Applications of Biotechnology in Oncology, Springer 2014

-Jain KK (ed). Applied Neurogenomics. Humana/Springer, January 2015.

-Jain KK. Textbook of Personalized Medicine, 3rd ed, Springer, 2020.

-Jain KK. Handbook of Nanomedicine, 3rd ed, Springer, 2017.

 -Jain KK. Handbook of Biomarkers, Springer, 2nd ed, 2017.

-Jain KK. Handbook of Neuroprotection, Springer, 2nd ed, 2019.

-Jain KK. Drug-induced Neurological Disorders, 4th ed, Springer, 2020. 

-Jain KK, Sharapov K. Essentials of Personalized Medicine (in Russian), LITERRA Publishing House, Moscow, Russia, 2019.

Web site: : http://www.pharmabiotech.ch

Contact: Prof. Dr. med. K. K. Jain

Last update of this entry: June 09, 2020